Paracrine-stimulated gene expression profile favors estradiol production in breast tumors

Molecular and Cellular Endocrinology

Volumn 253, Issue 1-2, 2006, Pages 44-55

  Amin, Sanober A ^a   Huang, Chiang Ching ^a   Reierstad, Scott ^a   Lin, Zhihong ^a   Arbieva, Zarema ^b   Wiley, Elizabeth ^b   Saborian, Hossain ^c   Haynes, Ben ^d   Cotterill, Helen ^d   Dowsett, Mitch ^d   Bulun, Serdar E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

AKR1C3; Aromatase; Breast adipose fibroblast; Breast cancer; Epithelial stromal interaction; Estrogen

Indexed keywords

ALDOKETOREDUCTASE 1 C3; ANDROSTENEDIONE; ANGIOGENIC FACTOR; AROMATASE; CELL SURFACE RECEPTOR; CYTOKINE; CYTOSKELETON PROTEIN; ENZYME; ESTRADIOL; ESTROGEN; MESSENGER RNA; OXIDOREDUCTASE; PROTEIN; SCLEROPROTEIN; TESTOSTERONE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADULT; ARTICLE; BENIGN TUMOR; BREAST CANCER; BREAST EPITHELIUM; BREAST TUMOR; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CARCINOMA IN SITU; CATALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; DNA MICROARRAY; EPITHELIUM CELL; ESTROGEN METABOLISM; ESTROGEN SYNTHESIS; EXPERIMENTAL MODEL; FEMALE; FIBROBLAST; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; INTRADUCTAL CARCINOMA; MALIGNANT NEOPLASTIC DISEASE; MULTIGENE FAMILY; PARACRINE SIGNALING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STROMA CELL; TESTOSTERONE SYNTHESIS; UPREGULATION;

3-HYDROXYSTEROID DEHYDROGENASES; ADIPOSE TISSUE; ADOLESCENT; ADULT; AROMATASE; BREAST NEOPLASMS; CELL LINE, TUMOR; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; ESTRADIOL; FEMALE; FIBROBLASTS; GENE EXPRESSION PROFILING; HUMANS; HYDROXYPROSTAGLANDIN DEHYDROGENASES; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PARACRINE COMMUNICATION; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33745403240     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2006.04.029     Document Type: Article

References (58)

1. Ackerman G.E., Smith M.E., Mendelson C.R., Macdonald P.C., and Simpson E.R. Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture. J. Clin. Endocrinol. Metab. 53 (1981) 412-417
2. Agarwal V.R., Bulun S.E., Leitch M., Rohrich R., and Simpson E.R. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients. J. Clin. Endocrinol. Metab. 81 (1996) 3843-3849
3. Allinen M., Beroukhim R., Cai L., Brennan C., Lahti-Domenici J., Huang H., Porter D., Hu M., Chin L., Richardson A., Schnitt S., Sellers W.R., and Polyak K. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6 (2004) 17-32
4. Bulun S.E., Lin Z., Imir G., Amin S., Demura M., Yilmaz B., Martin R., Utsunomiya H., Thung S., Gurates B., Tamura M., Langoi D., and Deb S. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol. Rev. 57 (2005) 359-383
5. Bulun S.E., Mahendroo M.S., and Simpson E.R. Aromatase gene expression in adipose tissue: relationship to breast cancer. J. Steroid Biochem. Mol. Biol. 49 (1994) 319-326
6. Bulun S.E., Price T.M., Aitken J., Mahendroo M.S., and Simpson E.R. A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J. Clin. Endocrinol. Metab. 77 (1993) 1622-1628
7. Bulun S.E., and Simpson E.R. Regulation of aromatase expression in human tissues. Breast Cancer Res. Treat. 30 (1994) 19-29
8. Clyne C.D., Speed C.J., Zhou J., and Simpson E.R. Liver receptor homologue-1 (LRH-1) regulates expression of aromatase in preadipocytes. J. Biol. Chem. 277 (2002) 20591-20597
9. Coombes R.C., Hall E., Gibson L.J., Paridaens R., Jassem J., Delozier T., Jones S.E., Alvarez I., Bertelli G., Ortmann O., Coates A.S., Bajetta E., Dodwell D., Coleman R.E., Fallowfield L.J., Mickiewicz E., Andersen J., Lonning P.E., Cocconi G., Stewart A., Stuart N., Snowdon C.F., Carpentieri M., Massimini G., and Bliss J.M. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N. Engl. J. Med. 350 (2004) 1081-1092
10. Crichton M.B., Nichols J.E., Zhao Y., Bulun S.E., and Simpson E.R. Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cells. Mol. Cell. Endocrinol. 118 (1996) 215-220
11. De Kretser D.M., Hedger M.P., Loveland K.L., and Phillips D.J. Inhibins, activins and follistatin in reproduction. Hum. Reprod. Update 8 (2002) 529-541
12. Deb S., Amin S., Imir A.G., Yilmaz M.B., Suzuki T., Sasano H., and Bulun S.E. Estrogen regulates expression of tumor necrosis factor receptors in breast adipose fibroblasts. J. Clin. Endocrinol. Metab. 89 (2004) 4018-4024
13. Deb S., Zhou J., Amin S.A., Imir A.G., Yilmaz M.B., Lin Z., and Bulun S.E. A novel role of sodium butyrate in cancer-associated aromatase promoters I.3 and II by disrupting a transcriptional complex in breast adipose fibroblasts. J. Biol. Chem. 281 (2006) 2585-2591
14. Desmond J.C., Mountford J.C., Drayson M.T., Walker E.A., Hewison M., Ride J.P., Luong Q.T., Hayden R.E., Vanin E.F., and Bunce C.M. The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs. Cancer Res. 63 (2003) 505-512
15. Dickson S.R., and Warburton M.J. Enhanced synthesis of gelatinase and stromelysin by myoepithelial cells during involution of the rat mammary gland. J. Histochem. Cytochem. 40 (1992) 697-703
16. Dufort I., Rheault P., Huang X.F., Soucy P., and Luu-the V. Characteristics of a highly labile human type 5 17beta-hydroxysteroid dehydrogenase. Endocrinology 140 (1999) 568-574
17. Evans C.T., Corbin C.J., Saunders C.T., Merrill J.C., Simpson E.R., and Mendelson C.R. Regulation of estrogen biosynthesis in human adipose stromal cells. Effects of dibutyryl cyclic AMP, epidermal growth factor, and phorbol esters on the synthesis of aromatase cytochrome P-450. J. Biol. Chem. 262 (1987) 6914-6920
18. Goss P.E., Ingle J.N., Martino S., Robert N.J., Muss H.B., Piccart M.J., Castiglione M., Tu D., Shepherd L.E., Pritchard K.I., Livingston R.B., Davidson N.E., Norton L., Perez E.A., Abrams J.S., Therasse P., Palmer M.J., and Pater J.L. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N. Engl. J. Med. 349 (2003) 1793-1802
19. Haagensen C.D. Diseases of the Breast. (1986), W.B. Saunders Company, Philadelphia
20. Harada N. Aberrant expression of aromatase in breast cancer tissues. J. Steroid Biochem. Mol. Biol. 61 (1997) 175-184
21. Heldin C.H., Miyazono K., and Ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390 (1997) 465-471
22. Hishikawa K., Oemar B.S., Tanner F.C., Nakaki T., Luscher T.F., and Fujii T. Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7. J. Biol. Chem. 274 (1999) 37461-37466
23. Hochberg R.B., Zielinski J.E., Larner J.M., and Pahuja S.L. Steroid esterification and hormone action (1991), Raven Press, New York
24. Howell A., Cuzick J., Baum M., Buzdar A., Dowsett M., Forbes J.F., Hoctin-Boes G., Houghton J., Locker G.Y., and Tobias J.S. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 365 (2005) 60-62
25. Irizarry R.A., Hobbs B., Collin F., Beazer-Barclay Y.D., Antonellis K.J., Scherf U., and Speed T.P. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4 (2003) 249-264
26. Ji Q., Aoyama C., Nien Y.D., Liu P.I., Chen P.K., Chang L., Stanczyk F.Z., and Stolz A. Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling. Cancer Res. 64 (2004) 7610-7617
27. Lewis M.J., Wiebe J.P., and Heathcote J.G. Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma. BMC Cancer 4 (2004) 27
28. Lin H.K., Steckelbroeck S., Fung K.M., Jones A.N., and Penning T.M. Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate. Steroids 69 (2004) 795-801
29. Liu Q.Y., Niranjan B., Gomes P., Gomm J.J., Davies D., Coombes R.C., and Buluwela L. Inhibitory effects of activin on the growth and morpholgenesis of primary and transformed mammary epithelial cells. Cancer Res. 56 (1996) 1155-1163
30. Mahendroo M.S., Mendelson C.R., and Simpson E.R. Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue. J. Biol. Chem. 268 (1993) 19463-19470
31. Matsuura K., Shiraishi H., Hara A., Sato K., Deyashiki Y., Ninomiya M., and Sakai S. Identification of a principal mRNA species for human 3alpha-hydroxysteroid dehydrogenase isoform (AKR1C3) that exhibits high prostaglandin D2 11-ketoreductase activity. J. Biochem. (Tokyo) 124 (1998) 940-946
32. Meng L., Zhou J., Sasano H., Suzuki T., Zeitoun K.M., and Bulun S.E. TNF alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction. Cancer Res. 61 (2001) 2250-2255
33. O'neill J.S., and Miller W.R. Aromatase activity in breast adipose tissue from women with benign and malignant breast diseases. Br. J. Cancer 56 (1987) 601-604
34. Oduwole O.O., Li Y., Isomaa V.V., Mantyniemi A., Pulkka A.E., Soini Y., and Vihko P.T. 17beta-hydroxysteroid dehydrogenase type 1 is an independent prognostic marker in breast cancer. Cancer Res. 64 (2004) 7604-7609
35. Pechoux C., Clezardin P., Dante R., Serre C.M., Clerget M., Bertin N., Lawler J., Delmas P.D., Vauzelle J.L., and Frappart L. Localization of thrombospondin, CD36 and CD51 during prenatal development of the human mammary gland. Differentiation 57 (1994) 133-141
36. Pelletier G., Luu-the V., Tetu B., and Labrie F. Immunocytochemical localization of type 5 17beta-hydroxysteroid dehydrogenase in human reproductive tissues. J. Histochem. Cytochem. 47 (1999) 731-738
37. Penning T.M. Molecular endocrinology of hydroxysteroid dehydrogenases. Endocr. Rev. 18 (1997) 281-305
38. Penning T.M., Burczynski M.E., Jez J.M., Hung C.F., Lin H.K., Ma H., Moore M., Palackal N., and Ratnam K. Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem. J. 351 (2000) 67-77
39. Penning T.M., Burczynski M.E., Jez J.M., Lin H.K., Ma H., Moore M., Ratnam K., and Palackal N. Structure-function aspects and inhibitor design of type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3). Mol. Cell. Endocrinol. 171 (2001) 137-149
40. Penning T.M., Jin Y., Steckelbroeck S., Lanisnik Rizner T., and Lewis M. Structure-function of human 3 alpha-hydroxysteroid dehydrogenases: genes and proteins. Mol. Cell. Endocrinol. 215 (2004) 63-72
41. Price T., Aitken J., Head J., Mahendroo M., Means G., and Simpson E. Determination of aromatase cytochrome P450 mRNA in human breast tissue by competitive polymerase chain reaction amplification. J. Clin. Endocrinol. Metab. 74 (1992) 1247-1252
42. Qin K., Ehrmann D.A., Cox N., Refetoff S., and Rosenfield R.L. Identification of a functional polymorphism of the human type 5 17{beta}-hydroxysteroid dehydrogenase gene associated with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. (2005)
43. Qin K., and Rosenfield R.L. Characterization of the basal promoter element of the human type 5 17beta-hydroxysteroid dehydrogenase gene. Biochim. Biophys. Acta 1728 (2005) 115-125
44. Quinkler M., Sinha B., Tomlinson J.W., Bujalska I.J., Stewart P.M., and Arlt W. Androgen generation in adipose tissue in women with simple obesity-a site-specific role for 17beta-hydroxysteroid dehydrogenase type 5. J. Endocrinol. 183 (2004) 331-342
45. Rudland P.S., Fernig D.G., and Smith J.A. Growth factors and their receptors in neoplastic mammary glands. Biomed. Pharmacother. 49 (1995) 389-399
46. Santen R.J., Martel J., Hoagland M., Naftolin F., Roa L., Harada N., Hafer L., Zaino R., and Santner S.J. Stromal spindle cells contain aromatase in human breast tumors. J. Clin. Endocrinol. Metab. 79 (1994) 627-632
47. Sebastian S., and Bulun S.E. A highly complex organization of the regulatory region of the human CYP19 (aromatase) gene revealed by the Human Genome Project. J. Clin. Endocrinol. Metab. 86 (2001) 4600-4602
48. Sebastian S., Takayama K., Shozu M., and Bulun S.E. Cloning and characterization of a novel endothelial promoter of the human CYP19 (aromatase P450) gene that is up-regulated in breast cancer tissue. Mol. Endocrinol. 16 (2002) 2243-2254
49. Sharma K.K., Lindqvist A., Zhou X.J., Auchus R.J., Penning T.M., and Andersson S. Deoxycorticosterone inactivation by AKR1C3 in human mineralocorticoid target tissues. Mol. Cell. Endocrinol. 248 (2006) 79-86
50. Simpson E.R., Merrill J.C., Hollub A.J., Graham-Lorence S., and Mendelson C.R. Regulation of estrogen biosynthesis by human adipose cells. Endocr. Rev. 10 (1989) 136-148
51. Suzuki T., Darnel A.D., Akahira J.I., Ariga N., Ogawa S., Kaneko C., Takeyama J., Moriya T., and Sasano H. 5alpha-reductases in human breast carcinoma: possible modulator of in situ androgenic actions. J. Clin. Endocrinol. Metab. 86 (2001) 2250-2257
52. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 5116-5121
53. Vihko P., Herrala A., Harkonen P., Isomaa V., Kaija H., Kurkela R., Li Y., Patrikainen L., Pulkka A., Soronen P., and Torn S. Enzymes as modulators in malignant transformation. J. Steroid Biochem. Mol. Biol. 93 (2005) 277-283
54. Warburton M.J., Mitchell D., Ormerod E.J., and Rudland P. Distribution of myoepithelial cells and basement membrane proteins in the resting, pregnant, lactating, and involuting rat mammary gland. J. Histochem. Cytochem. 30 (1982) 667-676
55. Wiebe J.P., and Lewis M.J. Activity and expression of progesterone metabolizing 5alpha-reductase, 20alpha-hydroxysteroid oxidoreductase and 3alpha(beta)-hydroxysteroid oxidoreductases in tumorigenic (MCF-7, MDA-MB-231, T-47D) and nontumorigenic (MCF-10A) human breast cancer cells. BMC Cancer 3 (2003) 9
56. Zhao Y., Agarwal V., and Simpson E.R. Prostaglandin (PG)E2 stimulates aromatase expression in adipose stromal cells via cAMP and promoter II. Abstracts IV International Aromatase Conference. Tahoe City, CA (1996) 14
57. Zhou D., Zhou C., and Chen S. Gene regulation studies of aromatase expression in breast cancer and adipose stromal cells. J. Steroid Biochem. Mol. Biol. 61 (1997) 273-280
58. Zhou J., Gurates B., Yang S., Sebastian S., and Bulun S.E. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta. Cancer Res. 61 (2001) 2328-2334